Not applicableActive, not recruitingINTERVENTIONAL
A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction
ClinicalTrials.gov · NCT03537586 · Registry updated: 2026-11-04
- Condition / research focus
- Coronary Microvascular Disease; Ischemic Heart Disease; Myocardial Ischemia
- Sponsor
- NYU Langone Health
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2018-06-29. Completion: 2035-06-30 (may be estimated). No results posted in this registry response.
Products and interventions (5)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Bivalirudin (drug) — also listed as: Angiomax
- Adenosine (drug) — also listed as: Adenoscan
- Heparin (drug)
- Pressure-Temperature Sensor Guidewire (device) — also listed as: Pressure Wire X
- Guiding Catheter (device) — also listed as: 6F Launcher Guide Catheter
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- New York University School of Medicine
New York, New York, United States
Site recruitment: Not reported